x min read

Stocks in Hot Concerns: Prospect Capital Corporation (NASDAQ:PSEC), Rex Energy Corporation (NASDAQ:REXX), NewLink Genetics Corporation (NASDAQ:NLNK)

Stocks in Hot Concerns: Prospect Capital Corporation (NASDAQ:PSEC), Rex Energy Corporation (NASDAQ:REXX), NewLink Genetics Corporation (NASDAQ:NLNK)
Written by
Ryan Mitchell
Published on
October 21, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Prospect Capital Corporation (NASDAQ:PSEC) reported that it has upsized its obtainable credit facilities to Onyx Payments, an H.I.G. Capital portfolio firm, by $86.1M to facilitate Onyx's recapitalization and purchases of Net Trans Services AS and Worldwide Payment Systems SA. Prospect is now the sole lender and agent of the first-lien senior secured debt issued by Onyx. Prospect Capital Corporation (NASDAQ:PSEC) stock hit highest price at $9.68, beginning with a price of $9.66 to the closed at 9.68 by a gain of 0.41% with a day range of $9.50-$9.68. The total volume of 4.11 Million shares held in the session was surprisingly higher than its average volume of 4210.49 shares.Rex Energy Corporation (NASDAQ:REXX) released its third quarter 2014 production volumes were 169.7 MMcfe/d, an surge of 72% over Q3 of 2013 and 32% over Q2 of 2014, consisting of 107.0 MMcf/d of natural gas and 10.4 Mboe/d of oil, condensate and NGLs. Oil, condensate and NGLs (including ethane) accounted for 37% of net production during the third quarter and increased 61% sequentially over Q2 of 2014. Shares of Rex Energy Corporation (NASDAQ:REXX) opened at $9.00 with 54.11 million outstanding shares and hit to its highest price of $9.20 during the day and finally closed at $8.56 by scoring -3.39%. In the whole session, it traded on volume of 1.93 Million shares, which turned higher than its average volume.NewLink Genetics Corporation (NASDAQ:NLNK) reported that they have signed into an exclusive worldwide license contract with Genentech, a member of the Roche Group, for the development of NLG919, NewLink's IDO pathway inhibitor. The parties also signed into a research partnership for the discovery of next generation IDO/TDO compounds. On the other consideration, NewLink Genetics Corporation (NASDAQ:NLNK) begun last trade with a price of $35.73 and throughout the trading session climbed at $36.75. The day-trade ended with a gain of 7.12% to closed at $31.44. The stock is going forward its fifty-two week low with 96.50% and lagging behind from its 52 week high price with -41.21%. NLNK last month stock price volatility remained 13.18%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You